← Companies|Scientus Pharma
Sc

Scientus Pharma

Toronto CAFounded 201430 employees
Private CapbiotechPrivateOncology
Platform: Pharma Cannabis
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
0
FDA Approved
2
Drug Pipeline (4 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
RimamavacamtenSCI-8982Preclinical2Bispecific AbGPRC5DSOS1iRettADPKD
SCI-2060SCI-2060Phase 22ASOJAK1MeniniNarcolepsyDravet
NidaratamabSCI-5595Approved2MultispecificC5FXIaiRAPsA
SCI-9998SCI-9998Approved2Small MoleculeUSP1FXIaiProstate Ca
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)
2025-06-18
Nidaratamab Ph3 Readout
RA
Past
2025-07-23
Nidaratamab Ph3 Readout
RA
Past
2025-09-02
SCI-2060 Ph2 Data
Narcolepsy
Past
2025-12-22
SCI-9998 Ph3 Readout
Prostate Ca
Past
2028-02-17
SCI-9998 Ph3 Readout
Prostate Ca
Ph3 Readout
2030-04-05
SCI-2060 Ph2 Data
Dravet
Ph2 Data
2030-06-12
Rimamavacamten Interim
Rett
Interim
2031-02-12
Rimamavacamten Interim
ADPKD
Interim